Insurance coverage for Ozempic and Wegovy varies, depending on everything from a person's medical diagnosis to where they live and their insurance plan.
Here is why GLP-1 medications might not be giving you the results you expect: Every Body Is Different
No, never change your anticoagulant or antiplatelet medication dosing or timing for injections
* *In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
How does nutrition relate to medication success
This data-driven approach not only supports adjustments in dosage and lifestyle but also mirrors the success seen in clinical trials, helping you tailor the therapy to your unique needs